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1.3.11 Strengthen early harm reduction responses to current and
emerging trends and patterns of drug use.
Establishing a working group to examine the evidence in relation to early
harm reduction responses, such as drug testing, amnesty bins and media
campaigns, to current and emerging trends including the use of new
psychoactive substances and image and performance enhancing drugs and




Community & Voluntary Sector
 






Safety Event Coordinator 
Stakeholders include: 
Review of Available Evidence
Subgroups Developed: 
Subgroup 1 - Drug Checking Methodologies 
Subgroup 2 - Medical, Educational & Safety Responses
International Experts Presenting: 
João Matias, EMCDDA
Daan van der Gouwe, Trimbos-instituut
Prof. Anton Luf, Medical University of Vienna
Night-time Economy (NTE)
Festivals 
Engagement with Young People 
Increasing potency re: MDMA & Cocaine
New psychoactive substances
Adverse health consequences, especially re: Mental Health 
source  Bojan Ilic Fotografie
Considerations regarding:












Faster Notifications Research & Funding
 
RECOMMENDATIONS
Development of a national working group to oversee research and training.
Formation of a national committee chaired by HSE Emergency Management to advise on
the development of standardised reporting templates for emergency critical medical care
at festivals and related events.
The development of a scientific oversight network is recommended, with appropriate
sourcing of a spectrum library of tested substances and facilitation of network sharing
among existing laboratories.
Evaluate and improve existing emerging drug trend reporting structures to provide real
time monitoring of trends. 
Notification of identified trends and alerts to be streamlined for effective and inclusive
communication.
A dedicated service/national volunteer training programme is required to provide education,
prevention and harm reduction services in the nighttime economy, similar to other European
services.
Continued Government support is necessary for resource development to target nightlife cohorts
through third-level and nightlife settings, as well as the progression of student and peer based
education and training on drugs, harm reduction and overdose prevention.
Festival and dance event licenses should include a requirement to provide approved drug
information and harm reduction strategies, as well as liaising with health officials on appropriate
communications & responses.
New research, with appropriate funding support is necessary to improve local knowledge
on the different populations who use drugs.
On-going funding should be available from Government for further developments in the
area of emerging drug trend monitoring.
Pilot a ‘back of house’ drug checking system in a festival setting collaborating with health care
providers and other relevant stakeholders with support from the Department of Justice and An
Garda Síochána. ‘Front of house’  approach should be considered if this pilot has positive results.
Analytical approaches require further discussion. GC-MS methodology is the preference by
Working Group experts and is recommended for drug checking. However, other methods or a
mixed method approach should be explored for use at festivals and nightlife events in the
interests of practicality.
Government consideration is required for the development of a dedicated laboratory for drug
market monitoring purposes, including stationary laboratories utilising robust technologies.
Single use reagent kits have benefits when used as part of an integrated harm reduction or
drug checking service, however, the Working Group does not recommend the dissemination of
these kits as a standalone harm reduction response.
The piloting and evaluation of other analytical approaches such as wastewater analysis, pooled
urine or syringe analysis can improve local monitoring and knowledge.

Recent European drug trends: the 
importance of a comprehensive 
approach
João Matias
Monitoring challenges in 2021 
2
• Big gaps in our knowledge…
• Reliability of surveys, response rates, users 
unaware of what they are using
• Rapidly evolving situation…
• Increasingly globalised drug market
• Growth of online and virtual drug markets
• Constant appearance of new substances
• Unexpected events – e.g. COVID-19
Drug use in Europe – how to measure 
3Photo by Fikri Rasyid on Unsplash
Core: National household 
surveys
- Face-to-face
- National prevalence data




- Indirect methods (for 
those who use in a more 
‘problematic’ way)
- Targeted surveys (eg
nightlife settings, 
festivals…)
Organised crime groups intensify drug production
4
370 laboratories dismantled in 2019:
Heroin Cocaine
Amphetamine    Methamphetamine
MDMA               GHB 
NPS 
Drugs of high potency or purity create serious public 
health risks – importance of services like drug checking
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Cannabis resin: average THC content 
20-28%
Cocaine: purity continues to increase
MDMA: increased tablet content and powder 
purity; products with hazardous levels
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Availability: wider selection of substances
Polydrug use: can intensify harms
Benzodiazepines: increase overdose risks
Cannabis: potent products, new forms and ways 
of consuming it
Patterns of use are becoming more complex
Impact of COVID-19
More digitally-enabled drug market
From nightlife to homelife 
Benzodiazepines raise concerns
7
Impact of COVID-19 – importance of almost real-






Vigilance needed to detect any increased use and 
harms
11
HCV: antibody prevalence in excess of 
50 % in 7 of 15 countries with national 
data
Drug-induced deaths: driven by opioids 
and other drugs
5 784 overdose deaths involving illicit 









Emerging drug trends in Ireland 
– analysis of survey data
Deirdre Mongan
National Drug and Alcohol 
Survey (NDAS) 2019/20
National Drug and Alcohol Survey  (NDAS) 
2019/20
• Survey to measure the extent and pattern of drug use 
among a representative sample (n=5,762) of those aged 15 
and over in Ireland.
• 2019/20 NDAS – 5th survey (previously undertaken 
2002/03, 2006/07, 2010/11 and 2014/15)
• Last year drug use among 15-64-year-olds – 9.0% (8.9% 
2014/15)
What drugs do people in Ireland use? (15-64 years)
The most commonly used drugs in the past 12 months were: 
1. Cannabis – 7.1%      (7.7% in 2014/15)
2. Ecstasy – 2.7%         (2.1%)
3. Cocaine powder* – 2.3%     (1.4%) 
4. Poppers* – 1.7%         (0.6%)
5. LSD* – 1.1%       (0.3%)
6. Amphetamines* – 1.0%     (0.3%)
*Statistically significant increase

































Trends in drug use since 
2002/03





















































15–24 25–34 15–24 25–34
Males Females
2002–03 4.2 2.2 1.4 1.2
2006–07 4.5 2.8 1.2 1.1
2010–11 1.3 0.9 1.0 0.4
2014–15 9.7 3.8 3.7 1.5













Trends in last year ecstasy use
Trends in last year cocaine use
15–24 25–34 15–24 25–34
Males Females
2002–03 4.3 1.8 1.1 0.8
2006–07 4.4 3.8 2.4 1.0
2010–11 3.9 4.0 1.1 1.7
2014–15 5.1 4.4 0.8 0.8

















Use of web surveys to capture 
trends in drug use
Use of web surveys
• Useful tool for collecting information on patterns of drug 
use
• In 2016 the EMCDDA started a pilot project — the 
European Web Survey on Drugs — to develop a system for 
collecting such data
• Ireland has participated in two web surveys – April 2020 & 
March-May 2021
• April 2020 – 662 participants (73% male; 27% female)

















































• Number of people using illegal drugs is unchanged but 
people using wider range of drugs
• Increase in use of cocaine, ecstasy, amphetamines, LSD, 
poppers
• Increase in stimulant use among 25-34 year old males and 
15-24 year old females
• Important to supplement these results with data from web 
surveys among people who use drugs.

Drug use and harm reduction 
practices among an Irish cohort of 
festival goers 
Prof Jo-Hanna Ivers, Assistant Professor in Addiction 
Trinity College Dublin  
 
Nicki Killeen, MA 
HSE National Social Inclusion Office  
Rationale 
Increased variety of 
drugs 
.  
Culture of intoxication 
 
Growing public health 
concern 
Knowledge gaps  
Q: What drugs 
are popular at 
festivals? 
Q: Who is using  and 
how? 
Q: Will people get 
medical help? 





Festival attendees  
• Male (54%) 
• Female (46.3%) 
• Other (0.4%) 
 
 
 • Employed  (52.5%) 
• Third-level student (42.8%) 
• Unemployed (2% ) 
• Average age 24 years old  
• Dublin, Cork, Kildare, 
Galway 
• Had used drugs (94.2%) 
• Poly use (86.8%) 




• Used at a festival abroad (53%) 
 
 
• Cited techno as preferred 
music genre (21.9%) 
 













1 24.9% 296 26.0% 309 
2 28.3% 336 28.8% 342 
3 24.7% 294 21.2% 252 
4 10.8% 129 9.8% 116 
5 4.3% 51 5.6% 66 
5+ 7.0% 83 8.7% 103 
Total   1,189   1,188 
Significance of festivals 
pre COVID-19 














Drug trends at festivals in Ireland and abroad  
 
• A known dealer 73.3% 
• A friend 55.1% 
• Unknown person/stranger 33.4% 
• Online 5.2%  
• Other 2.2% 
 
 
Sourcing drugs for festivals  
• Timing of purchase before 
event? 
• Relationship with dealer? 
• Friend technically supplier? 
• Buying from a stranger – last 
resort? 
• Role of social media and 
encrypted applications? 
• Surface web or darknet – what 
drugs? 
 
Reducing harm  
76%  
Leave time between 
doses  
88% 
Sip water  
48% 
Test dose  
18% 
Single use 
13% Other  
Other measures considered as risk reduction 
strategies  
Peers  Test kits and 
pill reports  Health and recovery 
Experience and guidance  
 




Allocating a “sober friend” 
 
“I only do it with friends 
who are experienced” 




An attempt to reduce 





Health and Wellbeing: Sexual Health   
Had sex at a festival following drug use  n % 
Yes 477 39.98 
No 716 60.02 
Had unprotected sex     
No 262 21.96 
Yes 316 26.49 
Had unprotected sex and sought STI test     
No 1,148 96.23 
Yes 45 3.77 
Unprotected sex and sought information     
No 1,185 99.33 
Yes 45 3.77 
Had unprotected sex and sought morning after pill     
Yes 23 1.93 
No 1,170 98.07 
*Consideration for sex / unprotected sex with partners  
Health and Wellbeing: Drug Emergencies  
• 22% (n=263) reported becoming unwell at a festival after drug use  
 
• Only one in five sough help (21%, n=54%)  
 
• Only 16% (n=192) would seek medical help following drug use if needed in the future  
 




“too scared of what will happen to me if i go” 
“First instinct would be to find a medical tent or ask someone to bring me. The quicker someone gets help the better” 
“Unless very very unwell I don't think I would, too scared, anxious, scared of being judged, and or 
prosecuted somehow” 
“many assume paramedics are going to immediately report drug use to the guards” 
Openness to health care interventions  
People want help to protect their health 
Drug Information at events 
85.08% 
Free condoms at event  
79.30% 
“Visibility, accessibility, reliability & 
confidentiality all very important” 
“ 
“Having had friends die from drug use, I understand the risks that are involved. However, I also 
understand that drug use will continue, and drug testing at festivals and in Irish cities is guaranteed 
to save lives” 
“A festival testing service is 
desperately needed to reduce harm” 
Drug checking settings 
96% 
Onsite services at a festival  
70% 
Community / fixed site  Use of amnesty bin to inform an alert 
system  
75% 
Lessons learned, gaps and next steps 
• Setting: Focus on festival setting  
• Social excluded groups: Use outside of the night-time economy 
• Females: New profile of users  
• Contents: Participants are unaware of the contents or substances actually taken 
• Changing drug market: Experiences and influence on practices and health?  
• Poly use: Rationale, dosing times, experiences 
• Safety: People want to protect their health but approaches cited have limitations  
• Responses: Fear of medical services but openness to utilise tailored services including drug 
checking or amnesty bins to inform public health alerts  
•Drug checking: Harm cannot be reduced without market monitoring and analysis  
• Research and Evaluation 
 
 
This report will, I hope, make an important contribution towards
improvements in this area and will help inform new areas of work to reduce
drug harms and protect the health of people who use drugs in Ireland. 
Ireland will engage with EU counterparts re: issues on emerging drug
trends.


